A life for the Research up to discovery of those guardians of the genome which together with others paved the way for personalized cancer therapiesProfessor spoke about it with emotion and pride. Antonio Giordano, oncologist and director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and also a professor in Siena.
"The discoveries made by me and my group have had a significant impact on the development of new diagnostic tests and therapies for cancers such as breast, prostate, and colon. These guardians of the genome are barriers - explained the oncologist - They protect the normal functioning of our body, and discovering them has led to intelligent drugs capable of correcting the damage when the genes finish their protective function. It has been a great satisfaction.", he added.
In the oncologist's research story, a life between Italy, the Campania His region of origin, and the United States, include discoveries that have changed the history of cancer treatment: the cyclins that govern the cell proliferation cycle, tumor suppressor genes such as RB2/p130, which he discovered, which has a primary function in the cell cycle and controls the correct replication of DNA, essentially preventing the onset of cancer.
"What is said in journalism about the tumor cell is that it goes crazy.", the scientist pointed out, that is "it proliferates uncontrollably, but today we have smart drugs." The commitment of Professor Giordano, among the United States And Italy has not lost its deep connection with its homeland. He authored a decisive report on the health risks of toxic waste in the Land of Fires.
It might interest you
Giordano: A gala on June 15th, Italy needs bright young people.
Is called Sbarro Health Research Organization, the organization founded by oncologist and scientist Antonio Giordano, who, with the discovery of the genome guardians, helped write a piece of history in cancer treatment. He recalled the organization's mission and the important event on June 15th, in Vico Equense, Naples, with a gala dedicated to research. Not just a simple ceremony, but a commitment to young people for "fund the brightest minds and research projects."
The SHRO "it was founded by me in 1992 - he recalled - with the help of a famous American businessman who philanthropically believed in my dream: to create an organization and independently fund the brightest minds and much-needed research projects on cancer, diabetes, and cardiovascular disease. In 1994, it became public, and today the organization works with universities, both American and Italian.
"A bridge" as Giordano calls it "from '92 to today it has financed more than 400 researchers for a minimum of 3 months to years who have trained in our laboratories and who today - he stressed - hold roles in universities or pharmaceutical companies around the world." According to the oncologist, the successful model is that of this organization which has invested in research and human resources, while this happens in associations or foundations which "a lot of funding is wasted in the structures." There's a desire for change in Italy that needs its brightest young people, Giordano is convinced. This is why Italian institutions will be present at the Gala, starting with the Minister of Health, Horace Schillaci.
Leave a comment